Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Dec;41(12):2444-2447.
doi: 10.2337/dci18-0041.

SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?

Affiliations
Comment

SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?

Matthew C Riddle et al. Diabetes Care. .

Comment on

Similar articles

See all similar articles

Cited by 2 articles

Publication types

Substances

LinkOut - more resources

Feedback